相关实验视频
Updated: Jun 29, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
562
慢性病患者的骨质疏松症管理 (ERCOS研究):科护理中的一个挑战
Jordi Bover1, Carlos Gómez-Alonso2, Enrique Casado3
1Servicio de Nefrología, Hospital Universitari Germans Trias i Pujol, REMAR-IGTP Group, Can Ruti Campus, Badalona, Barcelona, Spain.
Nefrologia
|March 26, 2024
概括
患有慢性病 (CKD) 的患者有高骨折风险,但骨折预防在临床实践中经常被忽视. 这项研究强调了为这些患者提供主动,多学科的护理的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 内部医学 内部医学
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 骨折风险评估是CKD-MBD指导方针的一部分,建议测试骨矿物质密度 (BMD).
- 关于慢性病患者骨折风险的临床实践仍然不太了解.
- ERCOS研究通过检查CKD患者的骨质疏松症和脆弱性骨折来解决这一差距.
研究的目的:
- 描述患有CKD G3-5D和骨质疏松症或脆弱性骨折的患者的个人资料.
- 分析治疗模式,并确定骨折预防策略中的差距.
- 倡导改善,协调治疗患有骨折风险的CKD患者.
主要方法:
- 一项涉及15家西班牙诊所 (脏病学,风湿病学,内科) 的多中心研究.
- 包括162名CKD G3-5D患者,重点关注骨质疏松症和/或脆弱性骨折患者.
- 收集有关患者人口统计,eGFR,透析状态,骨折史和治疗的数据.
主要成果:
- 脆弱性骨折的高患病率 (37.7%),主要是脊椎和部骨折.
- 患者往往有球体疾病和皮质类固醇使用史.
- 观察到严重的骨折预防治疗不足,特别是在脏病学环境中.
结论:
- 慢性病患者,特别是老年妇女,患有骨质疏松症和脆弱性骨折的负担很高.
- 目前的临床实践表明治疗不足,需要更积极地预防骨折.
- 标准化,多学科的护理对于解决差异和改善结果至关重要.
相关概念视频
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Renal Regulation of Acid-Base Balance
428
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
428
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Renal Drug Excretion: Overview
153
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
153
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Renal Drug Excretion: Tubular Secretion
180
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
180

